Kolexia
Gaymard Alexandre
Pharmacien
Hôpital La Croix-Rousse
Lyon, France
72 Activités
386 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Grippe humaine Infections à coronavirus Pneumopathie virale Pneumopathie infectieuse Infections de l'appareil respiratoire Infections à virus respiratoire syncytial Urgences Bronchiolite

Industries

Mérieux Université
18 collaboration(s)
Dernière en 2023
MERIEUX UNIVERSITE
3 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
DisCoVeRy: Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Essai Clinique (Institut National de la Santé Et de la Recherche Médicale, France)   24 novembre 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.
CPT: pharmacometrics & systems pharmacology   20 septembre 2023
SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results.
Viruses   24 avril 2023
Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin   26 janvier 2023
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
Emerging microbes & infections   27 octobre 2022
Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS-CoV-2 and monkeypox virus.
Journal of medical virology   21 septembre 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
The Journal of antimicrobial chemotherapy   02 mai 2022
SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant.
Viruses   28 avril 2022
IPCoVRS: Impact of the Covid-19 Pandemic on the Epidemiology of Respiratory Syncytial Virus
Essai Clinique (Hospices Civils de Lyon)   26 avril 2022